RegulatING chromatin regulators: Post-translational modification of the ING family of epigenetic regulators

Biochemical Journal

Volumn 450, Issue 3, 2013, Pages 433-442

  Satpathy, Shankha ^a   Nabbi, Arash ^a   Riabowol, Karl ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Acetylation; Chromatin; Epigenetics; Inhibitor of growth (ING); Stress; Tumour suppressor

Indexed keywords

GROWTH INHIBITOR; HISTONE DEACETYLASE; HISTONE H3; ING PROTEIN; ING1 PROTEIN; ING2 PROTEIN; ING3 PROTEIN; ING4 PROTEIN; ING5 PROTEIN; KARYOPHERIN; LYSINE; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ACETYLATION; CANCER GENE THERAPY; CELL INTERACTION; CELLULAR DISTRIBUTION; CHROMATIN STRUCTURE; CRYSTAL STRUCTURE; DNA DAMAGE; EPIGENETICS; GENE EXPRESSION; HALF LIFE TIME; HISTONE METHYLATION; HUMAN; INNATE IMMUNITY; METASTASIS; MUSCLE DEVELOPMENT; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN METHYLATION; PROTEIN MOTIF; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; SPERMATOGENESIS; SUMOYLATION; UBIQUITINATION;

ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; HOMEODOMAIN PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; MULTIGENE FAMILY; NUCLEAR PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84874643157     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121632     Document Type: Review

References (124)

1. Garkavtsev, I., Kazarov, A., Gudkov, A. and Riabowol, K. (1996) Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14, 415-420
2. Loewith, R., Meijer, M., Lees-Miller, S. P., Riabowol, K. and Young, D. (2000) Three yeast proteins related to the human candidate tumor suppressor p33(ING1) are associated with histone acetyltransferase activities. Mol. Cell. Biol. 20, 3807-3816
3. Garkavtsev, I., Demetrick, D. and Riabowol, K. (1997) Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1). Cytogenet. Cell Genet. 76, 176-178
4. Feng, X., Hara, Y. and Riabowol, K. (2002) Different HATS of the ING1 gene family. Trends Cell Biol. 12, 532-538
5. Soliman, M. A. and Riabowol, K. (2007) After a decade of study-ING, a PHD for a versatile family of proteins. Trends Biochem. Sci. 32, 509-519
6. Helbing, C. C., Veillette, C., Riabowol, K., Johnston, R. N. and Garkavtsev, I. (1997) A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res. 57, 1255-1258
7. Vieyra, D., Toyama, T., Hara, Y., Boland, D., Johnston, R. and Riabowol, K. (2002) ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Cancer Res. 62, 4445-4452
8. Shinoura, N., Muramatsu, Y., Nishimura, M., Yoshida, Y., Saito, A., Yokoyama, T., Furukawa, T., Horii, A., Hashimoto, M., Asai, A. et al. (1999) Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. Cancer Res. 59, 5521-5528
9. Soliman, M. A., Berardi, P., Pastyryeva, S., Bonnefin, P., Feng, X., Colina, A., Young, D. and Riabowol, K. (2008) ING1a expression increases during replicative senescence and induces a senescent phenotype. Aging Cell 7, 783-794
10. Nagashima, M., Shiseki, M., Miura, K., Hagiwara, K., Linke, S. P., Pedeux, R., Wang, X. W., Yokota, J., Riabowol, K. and Harris, C. C. (2001) DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc. Natl. Acad. Sci. U.S.A. 98, 9671-9676
11. Nagashima, M., Shiseki, M., Pedeux, R. M., Okamura, S., Kitahama-Shiseki, M., Miura, K., Yokota, J. and Harris, C. C. (2003) A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis. Oncogene 22, 343-350
12. Shiseki, M., Nagashima, M., Pedeux, R. M., Kitahama-Shiseki, M., Miura, K., Okamura, S., Onogi, H., Higashimoto, Y., Appella, E., Yokota, J. and Harris, C. C. (2003) p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity. Cancer Res. 63, 2373-2378
13. Pedeux, R., Sengupta, S., Shen, J. C., Demidov, O. N., Saito, S., Onogi, H., Kumamoto, K., Wincovitch, S., Garfield, S. H., McMenamin, M. et al. (2005) ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol. Cell. Biol. 25, 6639-6648
14. He, G. H., Helbing, C. C., Wagner, M. J., Sensen, C. W. and Riabowol, K. (2005) Phylogenetic analysis of the ING family of PHD finger proteins. Mol. Biol. Evol. 22, 104-116
15. Doyon, Y., Cayrou, C., Ullah, M., Landry, A. J., Cote, V., Selleck, W., Lane, W. S., Tan, S., Yang, X. J. and Cote, J. (2006) ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol. Cell 21, 51-64
16. Scott, M., Bonnefin, P., Vieyra, D., Boisvert, F. M., Young, D., Bazett-Jones, D. P. and Riabowol, K. (2001) UV-induced binding of ING1 to PCNA regulates the induction of apoptosis. J. Cell Sci. 114, 3455-3462
17. Cheung, Jr, K. J., Mitchell, D., Lin, P. and Li, G. (2001) The tumor suppressor candidate p33(ING1) mediates repair of UV-damaged DNA. Cancer Res. 61, 4974-4977
18. Vieyra, D., Loewith, R., Scott, M., Bonnefin, P., Boisvert, F. M., Cheema, P., Pastyryeva, S., Meijer, M., Johnston, R. N., Bazett-Jones, D. P. et al. (2002) Human ING1 proteins differentially regulate histone acetylation. J. Biol. Chem. 277, 29832-29839
19. Pena, P. V., Hom, R. A., Hung, T., Lin, H., Kuo, A. J., Wong, R. P., Subach, O. M., Champagne, K. S., Zhao, R., Verkhusha, V. V. et al. (2008) Histone H3K4me3 binding is required for the DNA repair and apoptotic activities of ING1 tumor suppressor. J. Mol. Biol. 380, 303-312
20. Kuzmichev, A., Zhang, Y., Erdjument-Bromage, H., Tempst, P. and Reinberg, D. (2002) Role of the Sin3-histone deacetylase complex in growth regulation by the candidate tumor suppressor p33(ING1). Mol. Cell. Biol. 22, 835-848
21. Toyama, T., Iwase, H., Yamashita, H., Hara, Y., Sugiura, H., Zhang, Z., Fukai, I., Miura, Y., Riabowol, K. and Fujii, Y. (2003) p33(ING1b) stimulates the transcriptional activity of the estrogen receptor α via its activation function (AF) 2 domain. J. Steroid Biochem. Mol. Biol. 87, 57-63
22. Toyama, T. and Iwase, H. (2004) p33ING1b and estrogen receptor (ER) α. Breast Cancer 11, 33-37
23. Campos, E. I., Martinka, M., Mitchell, D. L., Dai, D. L. and Li, G. (2004) Mutations of the ING1 tumor suppressor gene detected in human melanoma abrogate nucleotide excision repair. Int. J. Oncol. 25, 73-80
24. Kuo, W. H., Wang, Y., Wong, R. P., Campos, E. I. and Li, G. (2007) The ING1b tumor suppressor facilitates nucleotide excision repair by promoting chromatin accessibility to XPA. Exp. Cell Res. 313, 1628-1638
25. Wong, R. P., Lin, H., Khosravi, S., Piche, B., Jafarnejad, S. M., Chen, D. W. and Li, G. (2011) Tumour suppressor ING1b maintains genomic stability upon replication stress. Nucleic Acids Res. 39, 3632-3642
26. Abad, M., Moreno, A., Palacios, A., Narita, M., Blanco, F., Moreno-Bueno, G. and Palmero, I. (2011) The tumor suppressor ING1 contributes to epigenetic control of cellular senescence. Aging Cell 10, 158-171
27. Garkavtsev, I. and Riabowol, K. (1997) Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol. Cell. Biol. 17, 2014-2019
28. Larrieu, D., Ythier, D., Brambilla, C. and Pedeux, R. (2010) ING2 controls the G1 to S-phase transition by regulating p21 expression. Cell Cycle 9, 3984-3990
29. Zhang, X., Xu, L. S., Wang, Z. Q., Wang, K. S., Li, N., Cheng, Z. H., Huang, S. Z., Wei, D. Z. and Han, Z. G. (2004) ING4 induces G2/M cell cycle arrest and enhances the chemosensitivity to DNA-damage agents in HepG2 cells. FEBS Lett. 570, 7-12
30. Sarker, K. P., Kataoka, H., Chan, A., Netherton, S. J., Pot, I., Huynh, M. A., Feng, X., Bonni, A., Riabowol, K. and Bonni, S. (2008) ING2 as a novel mediator of transforming growth factor-β-dependent responses in epithelial cells. J. Biol. Chem. 283, 13269-13279
31. Colla, S., Tagliaferri, S., Morandi, F., Lunghi, P., Donofrio, G., Martorana, D., Mancini, C., Lazzaretti, M., Mazzera, L., Ravanetti, L. et al. (2007) The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1α (HIF-1α) activity: involvement in myeloma-induced angiogenesis. Blood 110, 4464-4475
32. Ozer, A., Wu, L. C. and Bruick, R. K. (2005) The candidate tumor suppressor ING4 represses activation of the hypoxia inducible factor (HIF). Proc. Natl. Acad. Sci. U.S.A. 102, 7481-7486
33. Ozer, A. and Bruick, R. K. (2005) Regulation of HIF by prolyl hydroxylases: recruitment of the candidate tumor suppressor protein ING4. Cell Cycle 4, 1153-1156
34. Shen, J. C., Unoki, M., Ythier, D., Duperray, A., Varticovski, L., Kumamoto, K., Pedeux, R. and Harris, C. C. (2007) Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin alpha1. Cancer Res. 67, 2552-2558
35. Li, J., Martinka, M. and Li, G. (2008) Role of ING4 in human melanoma cell migration, invasion and patient survival. Carcinogenesis 29, 1373-1379
36. Tallen, G., Farhangi, S., Tamannai, M., Holtkamp, N., Mangoldt, D., Shah, S., Suzuki, K., Truss, M., Henze, G., Riabowol, K. and von Deimling, A. (2009) The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells. Oncol. Res. 18, 95-105
37. Nozell, S., Laver, T., Moseley, D., Nowoslawski, L., De Vos, M., Atkinson, G. P., Harrison, K., Nabors, L. B. and Benveniste, E. N. (2008) The ING4 tumor suppressor attenuates NF-κB activity at the promoters of target genes. Mol. Cell. Biol. 28, 6632-6645
38. Garkavtsev, I., Kozin, S. V., Chernova, O., Xu, L., Winkler, F., Brown, E., Barnett, G. H. and Jain, R. K. (2004) The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428, 328-332
39. Eapen, S. A., Netherton, S. J., Sarker, K. P., Deng, L., Chan, A., Riabowol, K. and Bonni, S. (2012) Identification of a novel function for the chromatin remodeling protein ING2 in muscle differentiation. PLoS ONE 7, e40684
40. Mulder, K. W., Wang, X., Escriu, C., Ito, Y., Schwarz, R. F., Gillis, J., Sirokmany, G., Donati, G., Uribe-Lewis, S., Pavlidis, P. et al. (2012) Diverse epigenetic strategies interact to control epidermal differentiation. Nat. Cell Biol. 14, 753-763
41. Pena, P. V., Davrazou, F., Shi, X., Walter, K. L., Verkhusha, V. V., Gozani, O., Zhao, R. and Kutateladze, T. G. (2006) Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature 442, 100-103
42. Shi, X., Hong, T., Walter, K. L., Ewalt, M., Michishita, E., Hung, T., Carney, D., Pena, P., Lan, F., Kaadige, M. R. et al. (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442, 96-99
43. Martin, D. G. E., Baetz, K., Shi, X. B., Walter, K. L., MacDonald, V. E., Wlodarski, M. J., Gozani, O., Hieter, P. and Howe, L. (2006) The Yng1p plant homeodomain finger is a methyl-histone binding module that recognizes lysine 4-methylated histone H3. Mol. Cell. Biol. 26, 7871-7879
44. Kichina, J. V., Zeremski, M., Aris, L., Gurova, K. V., Walker, E., Franks, R., Nikitin, A. Y., Kiyokawa, H. and Gudkov, A. V. (2006) Targeted disruption of the mouse ing1 locus results in reduced body size, hypersensitivity to radiation and elevated incidence of lymphomas. Oncogene 25, 857-866
45. Coles, A. H., Liang, H., Zhu, Z., Marfella, C. G., Kang, J., Imbalzano, A. N. and Jones, S. N. (2007) Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis. Cancer Res. 67, 2054-2061
46. Saito, M., Kumamoto, K., Robles, A. I., Horikawa, I., Furusato, B., Okamura, S., Goto, A., Yamashita, T., Nagashima, M., Lee, T. L. et al. (2010) Targeted disruption of Ing2 results in defective spermatogenesis and development of soft-tissue sarcomas. PLoS ONE 5, e15541
47. Coles, A. H., Gannon, H., Cerny, A., Kurt-Jones, E. and Jones, S. N. (2010) Inhibitor of growth-4 promotes IκB promoter activation to suppress NF-κB signaling and innate immunity. Proc. Natl. Acad. Sci. U.S.A. 107, 11423-11428
48. Luo, J., Shah, S., Riabowol, K. and Mains, P. E. (2009) The Caenorhabditis elegans ing-3 gene regulates ionizing radiation-induced germ-cell apoptosis in a p53-associated pathway. Genetics 181, 473-482
49. Garkavtsev, I., Kazarov, A., Gudkov, A. and Riabowol, K. (1996) Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat. Genet. 14, 415-420
50. Russell, M. W., Soliman, M. A., Schriemer, D. and Riabowol, K. (2008) ING1 protein targeting to the nucleus by karyopherins is necessary for activation of p21. Biochem. Biophys. Res. Commun. 374, 490-495
51. Toyama, T., Iwase, H., Watson, P., Muzik, H., Saettler, E., Magliocco, A., DiFrancesco, L., Forsyth, P., Garkavtsev, I., Kobayashi, S. and Riabowol, K. (1999) Suppression of ING1 expression in sporadic breast cancer. Oncogene 18, 5187-5193
52. Ohmori, M., Nagai, M., Tasaka, T., Koeffler, H. P., Toyama, T., Riabowol, K. and Takahara, J. (1999) Decreased expression of p33ING1 mRNA in lymphoid malignancies. Am. J. Hematol. 62, 118-119
53. Oki, E., Maehara, Y., Tokunaga, E., Kakeji, Y. and Sugimachi, K. (1999) Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett. 147, 157-162
54. Kameyama, K., Huang, C. L., Liu, D., Masuya, D., Nakashima, T., Sumitomo, S., Takami, Y., Kinoshita, M. and Yokomise, H. (2003) Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients. Clin. Cancer Res. 9, 4926-4934
55. Tallen, G., Kaiser, I., Krabbe, S., Lass, U., Hartmann, C., Henze, G., Riabowol, K. and von Deimling, A. (2004) No ING1 mutations in human brain tumours but reduced expression in high malignancy grades of astrocytoma. Int. J. Cancer 109, 476-479
56. Takahashi, M., Ozaki, T., Todo, S. and Nakagawara, A. (2004) Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas. Oncol. Rep. 12, 811-816
57. Chen, L. S., Wei, J. B., Zhou, Y. C., Zhang, S., Liang, J. L., Cao, Y. F., Tang, Z. J., Zhang, X. L. and Gao, F. (2005) Genetic alterations and expression of inhibitor of growth 1 in human sporadic colorectal cancer. World J. Gastroenterol. 11, 6120-6124
58. Campos, E. I., Cheung, Jr, K. J., Murray, A., Li, S. and Li, G. (2002) The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines. Br. J. Dermatol. 146, 574-580
59. Zhang, H. K., Pan, K., Wang, H., Weng, D. S., Song, H. F., Zhou, J., Huang, W., Li, J. J., Chen, M. S. and Xia, J. C. (2008) Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Lett. 261, 183-192
60. Ythier, D., Brambilla, E., Binet, R., Nissou, D., Vesin, A., de Fraipont, F., Moro-Sibilot, D., Lantuejoul, S., Brambilla, C., Gazzeri, S. and Pedeux, R. (2010) Expression of candidate tumor suppressor gene ING2 is lost in non-small cell lung carcinoma. Lung Cancer 69, 180-186
61. Okano, T., Gemma, A., Hosoya, Y., Hosomi, Y., Nara, M., Kokubo, Y., Yoshimura, A., Shibuya, M., Nagashima, M., Harris, C. C. and Kudoh, S. (2006) Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer. Oncol. Rep. 15, 545-549
62. Lu, F., Dai, D. L., Martinka, M., Ho, V. and Li, G. (2006) Nuclear ING2 expression is reduced in human cutaneous melanomas. Br. J. Cancer 95, 80-86
63. Borkosky, S. S., Gunduz, M., Nagatsuka, H., Beder, L. B., Gunduz, E., Ali, M. A., Rodriguez, A. P., Cilek, M. Z., Tominaga, S., Yamanaka, N. et al. (2009) Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 135, 703-713
64. Kumamoto, K., Fujita, K., Kurotani, R., Saito, M., Unoki, M., Hagiwara, N., Shiga, H., Bowman, E. D., Yanaihara, N., Okamura, S. et al. (2009) ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. Int. J. Cancer 125, 1306-1315
65. Gunduz, M., Ouchida, M., Fukushima, K., Ito, S., Jitsumori, Y., Nakashima, T., Nagai, N., Nishizaki, K. and Shimizu, K. (2002) Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers. Oncogene 21, 4462-4470
66. Gunduz, M., Beder, L. B., Gunduz, E., Nagatsuka, H., Fukushima, K., Pehlivan, D., Cetin, E., Yamanaka, N., Nishizaki, K., Shimizu, K. and Nagai, N. (2008) Downregulation of ING3 mRNA expression predicts poor prognosis in head and neck cancer. Cancer Sci. 99, 531-538
67. Wang, Y., Dai, D. L., Martinka, M. and Li, G. (2007) Prognostic significance of nuclear ING3 expression in human cutaneous melanoma. Clin. Cancer Res. 13, 4111-4116
68. Gunduz, M., Nagatsuka, H., Demircan, K., Gunduz, E., Cengiz, B., Ouchida, M., Tsujigiwa, H., Yamachika, E., Fukushima, K., Beder, L. et al. (2005) Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas. Gene 356, 109-117
69. Li, M., Jin, Y., Sun, W. J., Yu, Y., Bai, J., Tong, D. D., Qi, J. P., Du, J. R., Geng, J. S., Huang, Q. et al. (2009) Reduced expression and novel splice variants of ING4 in human gastric adenocarcinoma. J. Pathol. 219, 87-95
70. Klironomos, G., Bravou, V., Papachristou, D. J., Gatzounis, G., Varakis, J., Parassi, E., Repanti, M. and Papadaki, H. (2010) Loss of inhibitor of growth (ING-4) is implicated in the pathogenesis and progression of human astrocytomas. Brain Pathol. 20, 490-497
71. Wang, Q. S., Li, M., Zhang, L. Y., Jin, Y., Tong, D. D., Yu, Y., Bai, J., Huang, Q., Liu, F. L., Liu, A. et al. (2010) Down-regulation of ING4 is associated with initiation and progression of lung cancer. Histopathology 57, 271-281
72. Li, X., Nishida, T., Noguchi, A., Zheng, Y., Takahashi, H., Yang, X., Masuda, S. and Takano, Y. (2010) Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma. J. Cancer Res. Clin. Oncol. 136, 1573-1583
73. Cengiz, B., Gunduz, M., Nagatsuka, H., Beder, L., Gunduz, E., Tamamura, R., Mahmut, N., Fukushima, K., Ali, M. A., Naomoto, Y. et al. (2007) Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer. Oral Oncol. 43, 241-247
74. Cengiz, B., Gunduz, E., Gunduz, M., Beder, L. B., Tamamura, R., Bagci, C., Yamanaka, N., Shimizu, K. and Nagatsuka, H. (2010) Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma. Int. J. Cancer 127, 2088-2094
75. Thakur, S., Feng, X., Qiao Shi, Z., Ganapathy, A., Kumar Mishra, M., Atadja, P., Morris, D. and Riabowol, K. (2012) ING1 and 5-azacytidine act synergistically to block breast cancer cell growth. PLoS ONE 7, e43671
76. Shimada, H., Liu, T. L., Ochiai, T., Shimizu, T., Haupt, Y., Hamada, H., Abe, T., Oka, M., Takiguchi, M. and Hiwasa, T. (2002) Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells. Oncogene 21, 1208-1216
77. Zhu, Y., Lv, H., Xie, Y., Sheng, W., Xiang, J. and Yang, J. (2011) Enhanced tumor suppression by an ING4/IL-24 bicistronic adenovirus-mediated gene cotransfer in human non-small cell lung cancer cells. Cancer Gene Ther. 18, 627-636
78. Xie, Y., Sheng, W., Miao, J., Xiang, J. and Yang, J. (2011) Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells. Cancer Gene Ther. 18, 176-188
79. Li, Z., Xie, Y., Sheng, W., Miao, J., Xiang, J. and Yang, J. (2010) Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo. Cancer Biother. Radiopharm. 25, 427-437
80. Yang, H. C., Sheng, W. H., Xie, Y. F., Miao, J. C., Wei, W. X. and Yang, J. C. (2009) In vitro and in vivo inhibitory effect of Ad-ING4 gene on proliferation of human prostate cancer PC-3 cells. Ai Zheng 28, 1149-1157
81. Xie, Y. F., Sheng, W., Xiang, J., Zhang, H., Ye, Z. and Yang, J. (2009) Adenovirus-mediated ING4 expression suppresses pancreatic carcinoma cell growth via induction of cell-cycle alteration, apoptosis, and inhibition of tumor angiogenesis. Cancer Biother. Radiopharm. 24, 261-269
82. Scott, M., Boisvert, F. M., Vieyra, D., Johnston, R. N., Bazett-Jones, D. P. and Riabowol, K. (2001) UV induces nucleolar translocation of ING1 through two distinct nucleolar targeting sequences. Nucleic Acids Res. 29, 2052-2058
83. Han, X., Feng, X., Rattner, J. B., Smith, H., Bose, P., Suzuki, K., Soliman, M. A., Scott, M. S., Burke, B. E. and Riabowol, K. (2008) Tethering by lamin A stabilizes and targets the ING1 tumour suppressor. Nat. Cell Biol. 10, 1333-1340
84. Eriksson, M., Brown, W. T., Gordon, L. B., Glynn, M. W., Singer, J., Scott, L., Erdos, M. R., Robbins, C. M., Moses, T. Y., Berglund, P. et al. (2003) Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293-298
85. Gozani, O., Karuman, P., Jones, D. R., Ivanov, D., Cha, J., Lugovskoy, A. A., Baird, C. L., Zhu, H., Field, S. J., Lessnick, S. L. et al. (2003) The PHD finger of the chromatin-associated protein ING2 functions as a nuclear phosphoinositide receptor. Cell 114, 99-111
86. Kaadige, M. R. and Ayer, D. E. (2006) The polybasic region that follows the plant homeodomain zinc finger 1 of Pf1 is necessary and sufficient for specific phosphoinositide binding. J. Biol. Chem. 281, 28831-28836
87. Thalappilly, S., Feng, X., Pastyryeva, S., Suzuki, K., Muruve, D., Larocque, D., Richard, S., Truss, M., von Deimling, A., Riabowol, K. and Tallen, G. (2011) The p53 tumor suppressor is stabilized by inhibitor of growth 1 (ING1) by blocking polyubiquitination. PLoS ONE 6, e21065
88. Culurgioni, S., Munoz, I. G., Palacios, A., Redondo, P., Blanco, F. J. and Montoya, G. (2010) Crystallization and preliminary X-ray diffraction analysis of the dimerization domain of the tumour suppressor ING4. Acta Crystallogr., Sect. F: Struct. Biol. Crystal. Commun. 66, 567-570
89. Champagne, K. S. and Kutateladze, T. G. (2009) Structural insight into histone recognition by the ING PHD fingers. Curr. Drug Targets 10, 432-441
90. Palacios, A., Garcia, P., Pad'ro, D., L'opez-Hern'andez, E., Martin, I. and Blanco, F. J. (2006) Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4. FEBS Lett. 580, 6903-6908
91. Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., Gnad, F., Cox, J., Jensen, T. S., Nigg, E. A. et al. (2010) Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signaling 3, ra3
92. Golebiowski, F., Matic, I., Tatham, M. H., Cole, C., Yin, Y., Nakamura, A., Cox, J., Barton, G. J., Mann, M. and Hay, R. T. (2009) System-wide changes to SUMO modifications in response to heat shock. Sci. Signaling 2, ra24
93. Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., Sowa, M. E., Rad, R., Rush, J., Comb, M. J. et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340
94. Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V. and Mann, M. (2009) Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325, 834-840
95. Wang, Z. H., Udeshi, N. D., Slawson, C., Compton, P. D., Sakabe, K., Cheung, W. D., Shabanowitz, J., Hunt, D. F. and Hart, G. W. (2010) Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci. Signaling 3, ra2
96. Zielinska, D. F., Gnad, F., Schropp, K., Wisniewski, J. R. and Mann, M. (2012) Mapping N-glycosylation sites across seven evolutionarily distant species reveals a divergent substrate proteome despite a common core machinery. Mol. Cell 46, 542-548
97. Choudhary, C. and Mann, M. (2010) Decoding signalling networks by mass spectrometry-based proteomics. Nat. Rev. Mol. Cell Biol. 11, 427-439
98. Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002) The protein kinase complement of the human genome. Science 298, 1912-1934
99. Gong, W., Russell, M., Suzuki, K. and Riabowol, K. (2006) Subcellular targeting of p33ING1b by phosphorylation-dependent 14-3-3 binding regulates p21WAF1 expression. Mol. Cell. Biol. 26, 2947-2954
100. Garate, M., Campos, E. I., Bush, J. A., Xiao, H. and Li, G. (2007) Phosphorylation of the tumor suppressor p33(ING1b) at Ser-126 influences its protein stability and proliferation of melanoma cells. FASEB J. 21, 3705-3716
101. Garate, M., Wong, R. P., Campos, E. I., Wang, Y. and Li, G. (2008) NAD(P)H quinone oxidoreductase 1 inhibits the proteasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep. 9, 576-581
102. Gnad, F., Gunawardena, J. and Mann, M. (2011) PHOSIDA 2011: the posttranslational modification database. Nucleic Acids Res. 39, D253-D260
103. Gnad, F., Ren, S., Cox, J., Olsen, J. V., Macek, B., Oroshi, M. and Mann, M. (2007) PHOSIDA (phosphorylation site database): management, structural and evolutionary investigation, and prediction of phosphosites. Genome Biol. 8, R250
104. Skowyra, D., Zeremski, M., Neznanov, N., Li, M., Choi, Y., Uesugi, M., Hauser, C. A., Gu, W., Gudkov, A. V. and Qin, J. (2001) Differential association of products of alternative transcripts of the candidate tumor suppressor ING1 with the mSin3/HDAC1 transcriptional corepressor complex. J. Biol. Chem. 276, 8734-8739
105. Hornbeck, P. V., Kornhauser, J. M., Tkachev, S., Zhang, B., Skrzypek, E., Murray, B., Latham, V. and Sullivan, M. (2012) PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res. 40, D261-D270
106. Van Damme, P., Arnesen, T. and Gevaert, K. (2011) Protein α-N-acetylation studied by N-terminomics. FEBS J. 278, 3822-3834
107. Yang, X. J. and Seto, E. (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31, 449-461
108. Komander, D. and Rape, M. (2012) The ubiquitin code. Annu. Rev. Biochem. 81, 203-229
109. Thrower, J. S., Hoffman, L., Rechsteiner, M. and Pickart, C. M. (2000) Recognition of the polyubiquitin proteolytic signal. EMBO J. 19, 94-102
110. Nie, J., Liu, L., Wu, M., Xing, G., He, S., Yin, Y., Tian, C., He, F. and Zhang, L. (2010) HECT ubiquitin ligase Smurf1 targets the tumor suppressor ING2 for ubiquitination and degradation. FEBS Lett. 584, 3005-3012
111. Chen, G., Wang, Y., Garate, M., Zhou, J. and Li, G. (2010) The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system. Oncogene 29, 1498-1508
112. Wagner, S. A., Beli, P., Weinert, B. T., Nielsen, M. L., Cox, J., Mann, M. and Choudhary, C. (2011) A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics 10, M111. 013284
113. Povlsen, L. K., Beli, P., Wagner, S. A., Poulsen, S. L., Sylvestersen, K. B., Poulsen, J. W., Nielsen, M. L., Bekker-Jensen, S., Mailand, N. and Choudhary, C. (2012) Systems-wide analysis of ubiquitylation dynamics reveals a key role for PAF15 ubiquitylation in DNA-damage bypass. Nat. Cell Biol. 14, 1089-1098
114. Guo, Q. and Fast, W. (2011) Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53. J. Biol. Chem. 286, 17069-17078
115. Gareau, J. R. and Lima, C. D. (2010) The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11, 861-871
116. Mahajan, R., Delphin, C., Guan, T., Gerace, L. and Melchior, F. (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107
117. Wohlschlegel, J. A., Johnson, E. S., Reed, S. I. and Yates, 3rd, J. R. (2006) Improved identification of SUMO attachment sites using C-terminal SUMO mutants and tailored protease digestion strategies. J. Proteome Res. 5, 761-770 117 Reference deleted
118. Gocke, C. B., Yu, H. and Kang, J. (2005) Systematic identification and analysis of mammalian small ubiquitin-like modifier substrates. J. Biol. Chem. 280, 5004-5012
119. Ganesan, A. K., Kho, Y., Kim, S. C., Chen, Y., Zhao, Y. and White, M. A. (2007) Broad spectrum identification of SUMO substrates in melanoma cells. Proteomics 7, 2216-2221
120. Flick, K. and Kaiser, P. (2009) Proteomic revelation: SUMO changes partners when the heat is on. Sci. Signaling 2, pe45
121. Ythier, D., Larrieu, D., Binet, R., Binda, O., Brambilla, C., Gazzeri, S. and Pedeux, R. (2010) Sumoylation of ING2 regulates the transcription mediated by Sin3A. Oncogene 29, 5946-5956
122. Wohlschlegel, J. A., Johnson, E. S., Reed, S. I. and Yates, 3rd, J. R. (2004) Global analysis of protein sumoylation in Saccharomyces cerevisiae. J. Biol. Chem. 279, 45662-45668
123. Xue, Y., Zhou, F., Fu, C., Xu, Y. and Yao, X. (2006) SUMOsp: a web server for sumoylation site prediction. Nucleic Acids Res. 34, W254-W257
124. Krogan, N. J., Cagney, G., Yu, H., Zhong, G., Guo, X., Ignatchenko, A., Li, J., Pu, S., Datta, N., Tikuisis, A. P. et al. (2006) Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature 440, 637-643